Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 123, Issue 2, 2002, Pages 280-287

  Battafarano, Richard J ^a   Piccirillo, Jay F ^a   Meyers, Bryan F ^a   Hsu, Han Shui ^a   Guthrie, Tracey J ^a   Cooper, Joel D ^a   Patterson, G Alexander ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMORBIDITY; DATA BASE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL ANALYSIS; SURVIVAL;

EID: 0036159974     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.119338     Document Type: Article

References (22)

1. Cancer statistics, 2001
2. Survival after resection of stage II non-small cell lung cancer
3. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer
4. Incidence of local recurrence and second primary tumors in resected stage I lung cancer
5. Revisions in the International System for Staging Lung Cancer
6. The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus
7. Inclusion of comorbidity into oncology data registries
8. Symptomatic patterns, biologic behavior, and prognosis in cancer of the lung: Practical application of Boolean algebra and clinical taxonomy
9. Symptoms as an index of biological behaviour and prognosis in human cancer
10. The epidemiology of cancer therapy, I: Clinical problems of statistical surveys
11. The epidemiology of cancer therapy, II: The clinical course: Data, decisions, and temporal demarcations
12. The epidemiology of cancer therapy, III: The management of imperfect data
13. The epidemiology of cancer therapy, IV: The extraction of data from medical records
14. On classifying cancers while treating patients
15. Prognostic determinants and a new view of staging for patients with nasopharyngeal carcinoma
16. Flaws in mortality data: The hazards of ignoring comorbid disease
17. Comorbidity and functional status in older women with breast cancer: Implications for screening, treatment, and prognosis
18. Prognostic value of clinical variables in invasive cervical cancer
19. New clinical severity staging system for cancer of the larynx: Five-year survival rates
20. Clinical symptoms and comorbidity: Significance for the prognostic classification of cancer
21. Clinical-severity staging system for oropharyngeal cancer: Five-year survival rates